Oncolytic viruses (OVs) have attracted growing awareness in the twenty-first century, as they
are generally considered to have direct oncolysis and cancer immune effects. With the …

Introduction To overcome the challenge of treating malignant brain tumors, oncolytic viruses
(OVs) represent an innovative therapeutic approach, featuring unique mechanisms of action …

Adoptive cell therapy using T cell receptor-engineered T cells (TCR-T) is a promising
approach for cancer therapy with an expectation of no significant side effects. In the human …

Lung cancer is the leading cause of cancer-related death worldwide. Although natural killer
(NK) cells are garnering interest as a potential anticancer therapy because they selectively …

Glioblastoma (GBM) is one of the most lethal cancers, having a poor prognosis and a
median survival of only about 15 months with standard treatment (surgery, radiation, and …

Oncolytic viruses (OVs), viruses engineered to lyse tumor cells, work hand in hand with the
immune response. While for decades the field isolated lytic capability and viral spread to …

A cardiac glycoside epoxide,(−)-cryptanoside A (1), was isolated from the stems of
Cryptolepis dubia collected in Laos, for which the complete structure was confirmed by …

Methods The relationship between IGF2BP3 and immune cell infiltration was analyzed using
online bioinformatics tools. Knockout of IGF2BP3 in mouse hepatoma cell line Hepa1-6 was …

Glioblastoma is the most common malignant primary brain tumor in adults. The prognosis is
extremely poor even with standard treatment of maximal safe resection, radiotherapy, and …

Glioblastoma (GBM), the predominant and primary malignant intracranial tumor, poses a
formidable challenge due to its immunosuppressive microenvironment, thereby confounding …